Nyxoah SA (EBR:NYXH)
5.63
-0.07 (-1.23%)
At close: Aug 14, 2025, 5:30 PM CET
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €213.38 million as of August 14, 2025. Its market cap has decreased by -16.78% in one year.
Market Cap
213.38M
Enterprise Value
172.43M
Revenue
4.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.63
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 213.38M, a decrease of -48.92%. That is a compound annual growth rate of -12.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 213.38M | -30.98% |
Dec 31, 2024 | 309.15M | 153.09% |
Dec 29, 2023 | 122.15M | -8.05% |
Dec 30, 2022 | 132.85M | -72.29% |
Dec 31, 2021 | 479.37M | 37.44% |
Dec 31, 2020 | 348.77M | -16.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UCB SA | 35.05B |
argenx SE | 34.79B |
Financière de Tubize | 6.70B |
Fagron NV | 1.51B |
Ion Beam Applications | 333.64M |
Onward Medical | 187.29M |
Hyloris Pharmaceuticals | 179.20M |
Sequana Medical NV | 71.87M |